Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)

Autor: Xu Liang, Adrien Briaux, Véronique Becette, Camille Benoist, Anais Boulai, Walid Chemlali, Anne Schnitzler, Sylvain Baulande, Sofia Rivera, Marie-Ange Mouret-Reynier, Laurence Venat Bouvet, Thibaut De La Motte Rouge, Jérôme Lemonnier, Florence Lerebours, Céline Callens

Publikováno v: Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-16 (2018)

Abstract Background Postmenopausal women with large, hormone receptor (HR)-positive/HER2-negative and low-proliferative breast cancer derived a benefit from neoadjuvant endocrine therapy (NET) in the CARMINA02 trial. This study was designed to correl

Externí odkaz: https://doaj.org/article/91f211b93baf478db3384b934c4d51f5

Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study

Autor: Virginie Fourchotte, Céline Callens, Vincent Servois, Sylvie Giacchetti, Walid Chemlali, Patricia Legoix, Paul Cottu, Brigitte Sigal Zafrani, Frédérique Berger, Mahasti Saghatchian, Lisa Belin, Anais Boulai, Keltouma Driouch, Mario Campone, Zakia Tariq, Rosette Lidereau, Anne Vincent Salomon, Ivan Bièche, Etienne Brain, Virginie Bernard, Sylvain Baulande, aurelie comte, Thomas Bachelot, François-Clément Bidard

Publikováno v: Genome Medicine, Vol 13, Iss 1, Pp 1-15 (2021)
Genome Medicine

Background Prognosis evaluation of advanced breast cancer and therapeutic strategy are mostly based on clinical features of advanced disease and molecular profiling of the primary tumor. Very few studies have evaluated the impact of metastatic subtyp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17485ee6ebcf77f818c26c3d1402dbb8
https://doaj.org/article/ad1f3e2cf70f4b9695dd17547b4a898c

Abstract PD1-06: Comparison of mutational landscapes of primary breast cancer and first metastatic relapse: Results from the ESOPE study

Autor: M. Campone, Vanessa Benhamo, PH Cottu, Anais Boulai, Céline Callens, Lisa Belin, Ivan Bièche, F-C Bidard, A Comte, Vincent Servois, A Vincent-Salomon, W Chemlali, Thomas Bachelot, Sylvie Giacchetti, Sylvain Baulande, B Sigal, Virginie Bernard, Egc Brain, J. Bonneterre, Patricia Legoix-Né

Publikováno v: Cancer Research. 77:PD1-06

Background Genomic profile of breast cancer metastases (M) may differ from that of the primary tumor (PT). In a multicenter prospective study (ESOPE, NCT 01956552) including 130 patients with biopsies of the first metastatic deposit, we have shown th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::af8ffa44de06470b54d2491d80e6b816
https://doi.org/10.1158/1538-7445.sabcs16-pd1-06

Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)

Autor: Anais Boulai, Jérôme Lemonnier, Thibaut De La Motte Rouge, Laurence Venat Bouvet, Marie-Ange Mouret-Reynier, Adrien Briaux, Céline Callens, Florence Lerebours, Sofia Rivera, Walid Chemlali, Véronique Becette, Anne Schnitzler, Camille Benoist, Sylvain Baulande, Xu Liang

Publikováno v: Journal of Hematology and Oncology
Journal of Hematology and Oncology, 2018, 11 (1), pp.124. ⟨10.1186/s13045-018-0670-9⟩
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-16 (2018)
Journal of Hematology and Oncology, BioMed Central, 2018, 11 (1), pp.124. ⟨10.1186/s13045-018-0670-9⟩
Journal of Hematology & Oncology

Background Postmenopausal women with large, hormone receptor (HR)-positive/HER2-negative and low-proliferative breast cancer derived a benefit from neoadjuvant endocrine therapy (NET) in the CARMINA02 trial. This study was designed to correlate gene

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a58d089cb09de4d4bc3c56d50428f60
https://hal.archives-ouvertes.fr/hal-01930042

Additional file 5: of Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer

Autor: Liang, Xu, Vacher, Sophie, Anais Boulai, Bernard, Virginie, Baulande, Sylvain, Mylene Bohec, BièChe, Ivan, Lerebours, Florence, CÊline Callens

Figure S3. DNA copy number alterations in the IBC cohort. The genes with DNA copy number alterations are grouped along the x axis, the percentage of samples with DNA copy number alterations shown on the y axis, DNA amplifications are indicated by bla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2fb9a64cff8a0b1418025c414fa80c